Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.320
+0.060 (4.76%)
At close: Mar 31, 2026, 4:00 PM EDT
1.344
+0.024 (1.81%)
Pre-market: Apr 1, 2026, 5:40 AM EDT

PACB Statistics

Total Valuation

PACB has a market cap or net worth of $398.64 million. The enterprise value is $821.55 million.

Market Cap398.64M
Enterprise Value 821.55M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, after market close.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

PACB has 302.00 million shares outstanding. The number of shares has increased by 9.28% in one year.

Current Share Class 302.00M
Shares Outstanding 302.00M
Shares Change (YoY) +9.28%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) 1.16%
Owned by Institutions (%) 64.15%
Float 294.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.49
Forward PS 2.25
PB Ratio 74.52
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.13
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.15, with a Debt / Equity ratio of 131.32.

Current Ratio 5.15
Quick Ratio 4.32
Debt / Equity 131.32
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -79.33

Financial Efficiency

Return on equity (ROE) is -213.45% and return on invested capital (ROIC) is -36.55%.

Return on Equity (ROE) -213.45%
Return on Assets (ROA) -33.73%
Return on Invested Capital (ROIC) -36.55%
Return on Capital Employed (ROCE) -77.56%
Weighted Average Cost of Capital (WACC) 6.62%
Revenue Per Employee $329,907
Profits Per Employee -$1.13M
Employee Count485
Asset Turnover 0.16
Inventory Turnover 1.95

Taxes

In the past 12 months, PACB has paid $318,000 in taxes.

Income Tax 318,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +15.79% in the last 52 weeks. The beta is 2.30, so PACB's price volatility has been higher than the market average.

Beta (5Y) 2.30
52-Week Price Change +15.79%
50-Day Moving Average 1.72
200-Day Moving Average 1.66
Relative Strength Index (RSI) 40.09
Average Volume (20 Days) 5,654,694

Short Selling Information

The latest short interest is 41.39 million, so 13.70% of the outstanding shares have been sold short.

Short Interest 41.39M
Short Previous Month 38.19M
Short % of Shares Out 13.70%
Short % of Float 14.03%
Short Ratio (days to cover) 6.60

Income Statement

In the last 12 months, PACB had revenue of $160.01 million and -$546.38 million in losses. Loss per share was -$1.82.

Revenue160.01M
Gross Profit 54.85M
Operating Income -551.66M
Pretax Income -546.06M
Net Income -546.38M
EBITDA -169.23M
EBIT -551.66M
Loss Per Share -$1.82
Full Income Statement

Balance Sheet

The company has $279.51 million in cash and $702.42 million in debt, with a net cash position of -$422.92 million or -$1.40 per share.

Cash & Cash Equivalents 279.51M
Total Debt 702.42M
Net Cash -422.92M
Net Cash Per Share -$1.40
Equity (Book Value) 5.35M
Book Value Per Share 0.02
Working Capital 302.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$111.21 million and capital expenditures -$2.71 million, giving a free cash flow of -$113.92 million.

Operating Cash Flow -111.21M
Capital Expenditures -2.71M
Depreciation & Amortization 382.44M
Net Borrowing n/a
Free Cash Flow -113.92M
FCF Per Share -$0.38
Full Cash Flow Statement

Margins

Gross Margin 34.28%
Operating Margin -344.78%
Pretax Margin -341.28%
Profit Margin n/a
EBITDA Margin -105.76%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PACB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.28%
Shareholder Yield -9.28%
Earnings Yield -137.06%
FCF Yield -28.58%

Analyst Forecast

The average price target for PACB is $2.13, which is 61.36% higher than the current price. The consensus rating is "Buy".

Price Target $2.13
Price Target Difference 61.36%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 11.47%
EPS Growth Forecast (5Y) -30.01%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PACB has an Altman Z-Score of -6.12 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.12
Piotroski F-Score 4